OHB’s order book is the kind most industrial companies would envy, and its adjusted profitability is climbing at a pace that outruns revenue. Yet the market’s reaction on the day tells a more complicated story: shares in the Bremen-based space group fell 6.5%, even as management reaffirmed its full-year guidance.
The tension sits in a single gap. For the first nine months of 2026, total output rose 10% to EUR 946.459 million. Adjusted EBITDA jumped 23% to EUR 99.679 million, and adjusted EBIT came in at EUR 66.9 million, 30% above the prior-year figure. Those are the numbers of a business gaining operating leverage. The number underneath them is not: net income slid 22% to EUR 19.137 million, down from EUR 24.384 million a year earlier. Earnings per share fell 20%, from EUR 1.20 to EUR 0.96.
That divergence is the crux of the investment case. Growth in adjusted operating profit only matters to shareholders if it eventually reaches the bottom line and shows up in free cash flow. On both counts, the third quarter raised questions rather than settling them.
Two Verdicts, One Tension
JPMorgan’s David Perry put the adjusted operating result for the third quarter 7% below the analyst consensus, with adjusted free cash flow also missing expectations. Reuters, meanwhile, reported that the quarterly EBITDA margin beat consensus by 1%, while free cash flow for the quarter came in at minus EUR 45 million. Perry’s point about long-term programmes is fair — individual quarters can swing sharply on milestone timing — but it also sharpens the question of whether contract execution reliably converts into earnings and cash over a full cycle.
Jefferies reads the period differently. Analyst Chloe Lemarie called the quarter solid at first glance, noting that softer revenue was offset by profitability. The firm reiterated its buy rating and a EUR 280 price target. Weighing the two views together: the margin performance is a genuine argument in OHB’s favour, while the cash outflow justifies a stricter look at execution. A convincing picture requires both operating margin and cash generation to carry their weight.
Should investors sell immediately? Or is it worth buying OHB SE?
A Backlog That Cuts Both Ways
After nine months, the order backlog stood at EUR 3.937 billion, with order intake of EUR 2.3 billion so far and a pipeline OHB pegs at roughly EUR 20 billion. That contracted base is the company’s core strength — but its value to shareholders depends on how profitably those programmes are worked off, and on whether the financing of the running business stays under control.
Management’s own benchmark for 2026 is unchanged: total output of around EUR 1.4 billion and an adjusted EBITDA margin of 10.5% to 11.0%. Reaffirming that guidance signals confidence in the current trajectory, provided the remaining months carry their share of the target.
The constructive read is that OHB has a formidable contract base and is lifting its adjusted operating returns. The more compelling equity story arrives when net income and free cash flow follow that trend with greater consistency. Until then, the quality of execution deserves closer attention than the sheer scale of the growth opportunity.
Ad
OHB SE Stock: Buy or Sell?! New OHB SE Analysis from November 12 delivers the answer:
The latest OHB SE figures speak for themselves: Urgent action needed for OHB SE investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 12.
OHB SE: Buy or sell? Read more here...
